Gene · 2925
Papers2,036
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,036
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cataract-causing Y204X mutation of crystallin protein CRYβB1 promotes its C-terminal degradation and higher-order oligomerization. | J Biol Chem | 2023 | 37356717 | PubTator, text mining | PubMed |
| The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2. | EJNMMI Res | 2023 | 37285007 | PubTator, text mining | PubMed |
| Dual targeting PET tracer [68Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study. | Theranostics | 2023 | 37284441 | PubTator, text mining | PubMed |
| The role of peptides in reversing chemoresistance of breast cancer: current facts and future prospects. | Front Pharmacol | 2023 | 37284316 | PubTator, text mining | PubMed |
| Derivation of the small-angle scattering profile of a target biomacromolecule from a profile deteriorated by aggregates. AUC-SAS. | J Appl Crystallogr | 2023 | 37284265 | PubTator, text mining | PubMed |
| The Application of Radiolabeled Targeted Molecular Probes for the Diagnosis and Treatment of Prostate Cancer. | Korean J Radiol | 2023 | 37271211 | PubTator, text mining | PubMed |
| Allosteric regulation of Senecavirus A 3Cpro proteolytic activity by an endogenous phospholipid. | PLoS Pathog | 2023 | 37253057 | PubTator, text mining | PubMed |
| Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists. | Pharmaceuticals (Basel) | 2023 | 37242457 | PubTator, text mining | PubMed |
| Nanoparticle-Based Radioconjugates for Targeted Imaging and Therapy of Prostate Cancer. | Molecules | 2023 | 37241862 | PubTator, text mining | PubMed |
| FDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast Carcinoma. | Biomedicines | 2023 | 37239021 | PubTator, text mining | PubMed |
| Insight into Pathogenic Mechanism Underlying the Hereditary Cataract Caused by βB2-G149V Mutation. | Biomolecules | 2023 | 37238733 | PubTator, text mining | PubMed |
| Nance-Horan Syndrome: characterization of dental, clinical and molecular features in three new families. | BMC Oral Health | 2023 | 37221585 | PubTator, text mining | PubMed |
| Modular One-Pot Strategy for the Synthesis of Heterobivalent Tracers. | ACS Med Chem Lett | 2023 | 37197474 | PubTator, text mining | PubMed |
| Current status of contemporary diagnostic radiotracers in the management of breast cancer: first steps toward theranostic applications. | EJNMMI Res | 2023 | 37195374 | PubTator, text mining | PubMed |
| Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R. | Cancers (Basel) | 2023 | 37190273 | PubTator, text mining | PubMed |
| The GRPR Antagonist [99mTc]Tc-maSSS-PEG2-RM26 towards Phase I Clinical Trial: Kit Preparation, Characterization and Toxicity. | Diagnostics (Basel) | 2023 | 37175001 | PubTator, text mining | PubMed |
| Multiplexed selectivity screening of anti-GPCR antibodies. | Sci Adv | 2023 | 37134173 | PubTator, text mining | PubMed |
| Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling. | RSC Med Chem | 2023 | 37122545 | PubTator, text mining | PubMed |
| Recent Development of Supramolecular Cancer Theranostics Based on Cyclodextrins: A Review. | Molecules | 2023 | 37110674 | PubTator, text mining | PubMed |
| Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis. | Int J Mol Sci | 2023 | 37108559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2925/papers?page=12